Vander Heide R S, Schwartz L M, Jennings R B, Reimer K A
Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA.
Cardiovasc Res. 1995 Nov;30(5):656-62. doi: 10.1016/0008-6363(95)00074-7.
Cardioprotective adaptation to brief periods of ischemia and reperfusion is termed ischemic preconditioning (PC). Limitation of infarct size by preconditioning is associated with marked slowing of ischemic metabolism. The cause of metabolic slowing has not been determined but may involve either pro- or anti-adrenergic mechanisms. Hypothetically, adrenergic stimulation could signal the adaptive response. Alternatively, metabolic slowing during the sustained ischemic challenge could occur through a reduction in beta-adrenergic stimulation. This study was designed to test the role of cardiac norepinephrine (NE) in PC.
The effect of PC on myocardial infarct size was studied in control dogs and dogs depleted of catecholamines by pretreatment with reserpine (RES; 0.25 mg/kg i.v.). PC was induced by four cycles of 5 min of ischemia and 5 min of reperfusion. Infarcts were produced by 60 min of ischemia and 3 h of reperfusion. Cardiac NE depletion was verified by radioimmunoassay of tissue samples and by absence of hemodynamic response to a tyramine bolus (1.4 mg/kg) administered at the end of each experiment. Infarct size, expressed as percent of area at risk, was controlled for variation in collateral blood flow using analysis of covariance (ANCOVA).
Adjusted mean infarct size was 25.5 +/- 3.2% in untreated controls vs. 19.1 +/- 3.3% in RES-treated controls (P = NS). PC limited infarct size in untreated dogs (7.4 +/- 1.8 vs. 25.5 +/- 3.2%; PC vs. control; P < 0.01) but not in RES-treated dogs (15.7 +/- 3.0% vs. 19.1 +/- 3.3%; RES + PC vs. RES; P = NS). Infarct size was larger in dogs with RES + PC than with PC alone, even though there was a trend toward a slight beneficial effect with RES alone.
The cardioprotective effect of ischemic preconditioning cannot be explained entirely as an anti-adrenergic effect. On the contrary, adrenergic receptor stimulation may be required for the full expression of ischemic preconditioning in canine myocardium.
对短暂缺血和再灌注的心脏保护适应性被称为缺血预处理(PC)。预处理对梗死面积的限制与缺血代谢的显著减慢有关。代谢减慢的原因尚未确定,但可能涉及促肾上腺素能或抗肾上腺素能机制。假设肾上腺素能刺激可以引发适应性反应。或者,在持续缺血挑战期间代谢减慢可能通过β-肾上腺素能刺激的减少而发生。本研究旨在测试心脏去甲肾上腺素(NE)在PC中的作用。
在对照犬和通过利血平(RES;0.25mg/kg静脉注射)预处理使儿茶酚胺耗竭的犬中研究PC对心肌梗死面积的影响。通过5分钟缺血和5分钟再灌注的四个周期诱导PC。通过60分钟缺血和3小时再灌注产生梗死。在每个实验结束时,通过组织样本的放射免疫测定以及对给予的酪胺推注(1.4mg/kg)无血流动力学反应来证实心脏NE耗竭。梗死面积以危险区域面积的百分比表示,使用协方差分析(ANCOVA)来控制侧支血流的变化。
未经治疗的对照犬调整后的平均梗死面积为25.5±3.2%,而RES治疗的对照犬为19.1±3.3%(P=无显著性差异)。PC限制了未经治疗犬的梗死面积(7.4±1.8对25.5±3.2%;PC对对照;P<0.01),但在RES治疗的犬中没有(15.7±3.0%对19.1±3.3%;RES+PC对RES;P=无显著性差异)。尽管单独使用RES有轻微有益作用的趋势,但RES+PC组犬的梗死面积比单独使用PC组更大。
缺血预处理的心脏保护作用不能完全解释为抗肾上腺素能作用。相反,肾上腺素能受体刺激可能是犬心肌中缺血预处理充分表达所必需的。